Dr. Reddy's Laboratories Limited (FRA:RDDA)

Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	9,297	10,321	11,403	8,604	8,475	8,726
Market Cap Growth	-27.34%	-9.49%	32.53%	1.52%	-2.88%	39.74%
Enterprise Value	9,192	10,267	10,816	8,258	8,392	8,780
Last Close Price	10.90	12.24	13.66	10.33	9.88	10.22
PE Ratio	17.33	16.86	18.41	17.03	30.32	43.47
PS Ratio	2.84	2.93	3.67	3.12	3.33	3.95
PB Ratio	2.61	2.83	3.65	3.32	3.75	4.33
P/TBV Ratio	3.81	4.24	4.28	3.92	4.50	5.64
P/FCF Ratio	26.76	50.37	35.31	16.14	53.13	28.86
P/OCF Ratio	15.54	20.53	22.56	13.04	25.42	20.99
EV/Sales Ratio	2.90	2.91	3.48	3.00	3.30	3.97
EV/EBITDA Ratio	11.64	10.67	12.26	11.16	14.82	16.50
EV/EBIT Ratio	15.06	12.98	14.82	13.79	19.70	22.91
EV/FCF Ratio	26.46	50.10	33.49	15.50	52.61	29.04
Debt / Equity Ratio	0.18	0.14	0.07	0.06	0.18	0.18
Debt / EBITDA Ratio	0.79	0.52	0.25	0.20	0.71	0.66
Debt / FCF Ratio	1.85	2.47	0.69	0.28	2.52	1.17
Asset Turnover	0.66	0.74	0.79	0.80	0.77	0.76
Inventory Turnover	2.06	2.01	2.06	2.14	2.09	2.15
Quick Ratio	1.18	1.16	1.72	1.58	1.24	1.07
Current Ratio	1.88	1.92	2.58	2.38	1.93	1.78
Return on Equity (ROE)	16.10%	18.53%	21.77%	21.38%	12.96%	10.51%
Return on Assets (ROA)	7.96%	10.37%	11.56%	10.86%	8.04%	8.27%
Return on Invested Capital (ROIC)	14.38%	19.98%	25.30%	21.99%	15.03%	13.42%
Return on Capital Employed (ROCE)	16.40%	20.10%	22.50%	22.60%	18.10%	18.10%
Earnings Yield	5.77%	5.93%	5.43%	5.87%	3.30%	2.30%
FCF Yield	3.74%	1.98%	2.83%	6.19%	1.88%	3.46%
Dividend Yield	0.53%	0.71%	0.65%	0.87%	0.72%	0.57%
Payout Ratio	11.77%	11.78%	11.94%	11.05%	17.59%	24.06%
Buyback Yield / Dilution	0.15%	-0.08%	-0.19%	-0.03%	-0.01%	-0.14%
Total Shareholder Return	0.68%	0.63%	0.46%	0.84%	0.71%	0.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.